Breaking News, Collaborations & Alliances

BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services

Will support new medical countermeasure research in the fight against emerging infectious disease.

By: Contract Pharma

Contract Pharma Staff

Pharm-Olam, a global clinical research organization (CRO), has been selected by the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response, to join its Clinical Studies Network. Under the terms of the contract, Pharm-Olam will provide routine and/or response clinical services for the advanced development of medical countermeasures (MCMs).     Pharm-Olam’s co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters